Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
oleh: Craig F. Teller, MD, Annie Chiu, MD, Cameron D. Chesnut, MD, Deborah Sherman, MD, José Raul Montes, MD, Sara Gaspard, MD, Terrence Keaney, MD, Neil S. Sadick, MD, Steve Yoelin, MD, Sara Sangha, PhD, Sachin M. Shridharani, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2021-07-01 |
Deskripsi
Background:. Submental fat can be reduced with ATX-101 (deoxycholic acid injection), a customizable and minimally invasive alternative to liposuction. In the years since its approval, the treatment patterns of ATX-101 have evolved. Methods:. A panel of experienced physicians from the United States gathered to generate best practices for the use of ATX-101 in submental contouring. Results:. The expert panel provided their insights on appropriate patient selection, managing patient expectations of ATX-101 treatment outcomes, and adverse events, and guidance on ATX-101 administration for optimal outcomes are presented here. Conclusion:. These best clinical practices on the use of ATX-101 for the reduction of submental fat should enable physicians to enhance the patient treatment experience and outcomes.